Edward Lear, developmental biology, immunology, disease & medicine
Researchers Turn to Implantable Robots to Regenerate Tissue
Researchers Turn to Implantable Robots to Regenerate Tissue
Shawna Williams | May 1, 2018
The devices, which could one day treat children with esophageal atresia and short bowel, were recently tested in pigs.
Colorblindness Study Reveals Unexpected Way to Make Blood Vessels
Colorblindness Study Reveals Unexpected Way to Make Blood Vessels
Ashley Yeager | May 1, 2018
Researchers stumbled across the connection while searching for ways to reduce vision problems in people with achromatopsia.
Studies Show How Cells Differentiate at Life’s Beginning
Studies Show How Cells Differentiate at Life’s Beginning
Shawna Williams | Apr 27, 2018
A trio of papers provide new insight into embryo development.
Preterm Labor May Be Sparked by Fetal Immune Reaction
Preterm Labor May Be Sparked by Fetal Immune Reaction
Ruth Williams | Apr 25, 2018
Immune cells targeting maternal antigens are abundant in the blood of premature infants, suggesting fetal intolerance of mom may instigate early labor.  
Image of the Day: Immune Cell In Action
Image of the Day: Immune Cell In Action
The Scientist Staff | Apr 23, 2018
By combining two new microscopy technologies, researchers filmed immune cells toiling away in the inner ear of a living zebrafish.
Antibody Combo Expands Response to Checkpoint Inhibitor in Mice
Antibody Combo Expands Response to Checkpoint Inhibitor in Mice
Kerry Grens | Apr 16, 2018
Genetic analyses uncover cellular hallmarks of bladder cancer tumors that don’t respond, but interfering with one of those characteristics in a mouse model causes tumors to shrink.  
Birth Defects Linked to Increased Risk of Childhood Cancer
Birth Defects Linked to Increased Risk of Childhood Cancer
Jim Daley | Apr 15, 2018
Certain non-chromosomal defects are strongly associated with specific childhood cancers.
New Ovarian Cancer Vaccine Shows Promise
New Ovarian Cancer Vaccine Shows Promise
Catherine Offord | Apr 12, 2018
A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.
Some Antibiotics Rev Up Host Immune Response to Viruses
Some Antibiotics Rev Up Host Immune Response to Viruses
Shawna Williams | Apr 9, 2018
The antimicrobial drug neomycin protects mice from some viral infections, complicating the picture of the relationship between antibiotics and susceptibility to viruses.
Opinion: We Have Been Naive About Naive T Cells
Opinion: We Have Been Naive About Naive T Cells
José A.M. Borghans, Femke van Wijk, Theo van den Broek | Apr 6, 2018
Human naive T cells are far more heterogeneous than has long been appreciated, having implications for vaccine strategies.